Editas Expands CRISPR Capabilities through New Technology Licensing - Genetic Engineering & Biotechnology News

Editas Expands CRISPR Capabilities through New Technology Licensing
Genetic Engineering & Biotechnology News
Officials at Editas Medicine say they exclusively licensed intellectual property related to new CRISPR technologies for human therapeutics. These global licensing agreements include intellectual property owned by the Broad Institute of MIT and Harvard ...and more »